Stocks and Investing
Stocks and Investing
Fri, September 20, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Kristen Kluska Reiterated (ADMA) at Buy and Held Target at $20 on, Sep 20th, 2024
Kristen Kluska of Cantor Fitzgerald, Reiterated "ADMA Biologics, Inc." (ADMA) at Buy and Held Target at $20 on, Sep 20th, 2024.
Kristen has made no other calls on ADMA in the last 4 months.
There are 2 other peers that have a rating on ADMA. Out of the 2 peers that are also analyzing ADMA, 0 agree with Kristen's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Kristen
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $18 on, Monday, August 12th, 2024
- Anthony Petrone of "Mizuho" Maintained at Strong Buy with Increased Target to $14 on, Thursday, June 20th, 2024
Contributing Sources